• No results found

[PDF] Top 20 Performance Volatility Index for Indian Pharmaceutical Industry

Has 10000 "Performance Volatility Index for Indian Pharmaceutical Industry" found on our website. Below are the top 20 most common "Performance Volatility Index for Indian Pharmaceutical Industry".

Performance Volatility Index for Indian Pharmaceutical Industry

Performance Volatility Index for Indian Pharmaceutical Industry

... sophisticated drug manufacturing techniques came into existence as a result of developing systematic scientific approaches, understanding human biology (including DNA). This development made it necessary to enact ... See full document

11

Impact of R and D Intensity, Patents and Regulatory Filings on Export Intensity of Indian Pharmaceutical Industry

Impact of R and D Intensity, Patents and Regulatory Filings on Export Intensity of Indian Pharmaceutical Industry

... export performance in drugs, chemicals and pharmaceutical ...2005, Indian pharmaceutical sector had seen a significant increase in R and D ...the Indian pharmaceutical sector had ... See full document

11

Performance of the Heston’s Stochastic Volatility Model: A Study in Indian Index Options Market

Performance of the Heston’s Stochastic Volatility Model: A Study in Indian Index Options Market

... Equity Data: In addition to the options data, certain filtering criteria are employed to screen the data for Nifty spot prices as well. Transactions during sessions which do not reflect the normal market behaviour, like ... See full document

15

An overview of unorganized retail pharmacy in Indian pharmaceutical industry

An overview of unorganized retail pharmacy in Indian pharmaceutical industry

... The Indian Pharmaceutical market (IPM) accounts for ...global pharmaceutical industry in term of value and 10% in volume ...Currently Indian pharmaceutical industry is ... See full document

8

The Testing of Efficient Market Hypotheses: A Study of Indian Pharmaceutical Industry

The Testing of Efficient Market Hypotheses: A Study of Indian Pharmaceutical Industry

... the Indian pharmaceutical companies support efficient market hypotheses (EMH) and examine the efficiency of the Indian stock market in three forms, ...listed pharmaceutical companies for the ... See full document

9

Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies

Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies

... quality and resorting to joint ventures with overseas strategic partners has been crucial for higher export performance. In 1997, the company has set up a joint venture with Uzpharmprom in Uzbekistan for ... See full document

69

Correlates of Index Futures and Spot Index Volatility: A Study of Indian Stock Market

Correlates of Index Futures and Spot Index Volatility: A Study of Indian Stock Market

... post-derivatives performance of spot index depicts a different picture in comparison to the pre-derivatives ...records volatility at ...jump volatility by 46.90% and in the same quarter the ... See full document

8

MODELING INDIAN MONSOON (RAINFALL) VOLATILITY AS AN INDEX BASED RISK TRANSFER PRODUCT

MODELING INDIAN MONSOON (RAINFALL) VOLATILITY AS AN INDEX BASED RISK TRANSFER PRODUCT

... an industry that is still in its evolution stages in this ...Rainfall index (RI) insurance introduced by leading insurance companies in India in the recent past holds better prospects over traditional crop ... See full document

14

Determinants of Capital Structure of Indian Pharmaceutical Industry

Determinants of Capital Structure of Indian Pharmaceutical Industry

... its industry class, size and operating ...the Indian Banking sector and concluded that liquidity, size, efficiency, growth, quality of assets, profitability and service diversification are the most ... See full document

5

Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry

Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry

... R&D performance of Indian pharmaceutical firms has come out with a positive coefficient statistically different from zero at 1% significance ...R&D performance of pharmaceutical ... See full document

31

Symbiotic Relationship between a Healthy Population and a Sustainable Economy: Financial Performance of Julphar Gulf Pharmaceutical Industries

Symbiotic Relationship between a Healthy Population and a Sustainable Economy: Financial Performance of Julphar Gulf Pharmaceutical Industries

... currency volatility is questionable, despite the fact that the government has implemented a fixed exchange rate against the ...rate volatility, hyper-inflation, and the like, especially in those countries ... See full document

8

 A REVIEW OF INFLUENCE OF THE GENERIC DRUG USER FEES ACT UPON THE EXPORT FROM THE INDIAN PHARMACEUTICAL INDUSTRY

 A REVIEW OF INFLUENCE OF THE GENERIC DRUG USER FEES ACT UPON THE EXPORT FROM THE INDIAN PHARMACEUTICAL INDUSTRY

... several Pharmaceutical firm’s ...some Indian companies, ANDA approvals have improved by over 50% between the periods Apr-Sept ...various Pharmaceutical companies all over the world 3 ... See full document

6

Indian Pharmaceutical Industry: A study of the post-liberalization period

Indian Pharmaceutical Industry: A study of the post-liberalization period

... Indian Pharmaceutical Industry: Trends and patterns Strategic government policies adopted after independence were the main factors that transformed the Indian pharmaceutical ... See full document

5

Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?

Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?

... the Indian pharmaceutical ...the Indian pharmaceutical firms, given the nature of their ownership ...the Indian pharmaceutical industry has been embedded into a four stage ... See full document

71

Mergers, Acquisitions and Firms’ Performance: Experience of Indian Pharmaceutical Industry

Mergers, Acquisitions and Firms’ Performance: Experience of Indian Pharmaceutical Industry

... the Indian Patent Act (1970) in 1999, 2002 and 2005 in particular, the present paper makes an attempt to examine the impact of MA on financial performance of Indian pharmaceutical ... See full document

16

An empirical study on financial performance of indian pharmaceutical industry

An empirical study on financial performance of indian pharmaceutical industry

... The Indian pharmaceuticals market increased at a CAGR of ...three pharmaceutical markets by incremental growth and sixth largest market globally in absolute ... See full document

6

Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance

Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance

... the performance analysis carried out, which shows that there is a significant difference in the marketing expenditure of merging firms compared to the non-merging counterparts during the post merger ...this ... See full document

21

Identification of pharmaceutical quality dashboard pharmaceutical industry

Identification of pharmaceutical quality dashboard pharmaceutical industry

... demonstrates pharmaceutical quality dashboard, is a visual display of the pharmaceutical industry critical quality metrics information to steer industry to meet quality vision and overall ... See full document

5

Price Discovery and Volatility Spillovers in Indian Spot Futures Commodity Market

Price Discovery and Volatility Spillovers in Indian Spot Futures Commodity Market

... and volatility spillovers in Indian spot-futures commodity markets through Johansen cointegration, Vector Error Correction Model (VECM) and the bivariate EGARCH ...composite index of metals, energy ... See full document

18

Identification of pharmaceutical quality metrics: pharmaceutical industry

Identification of pharmaceutical quality metrics: pharmaceutical industry

... The primary data has been collected in the year 2017 from 83 managers. The managers were from European Medicines Agency (EMA), United States Food and Drug Administration pharmaceutical firms with several years of ... See full document

5

Show all 10000 documents...